search
Back to results

Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients

Primary Purpose

Cell- and Tissue-Based Therapy

Status
Unknown status
Phase
Early Phase 1
Locations
Indonesia
Study Type
Interventional
Intervention
Amnion only
Amnion - endometrium cells
Amnion - amnion epithelial cells
Amnion-EnSC-AESC
Sponsored by
Indonesia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cell- and Tissue-Based Therapy focused on measuring Endometrial stem cells, Amnion epithelial stem cells, Amnion bilayer, Thin endometrium, Secondary amenorrhoe

Eligibility Criteria

undefined - 40 Years (Child, Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with thin endometrium without scar
  • Patients with acute thin endometrium post-therapy (medicamentosa)
  • Patients who are willing to participate in the study

Exclusion Criteria:

  • Patients with thin endometrium due to TB
  • Patients with cancer in the reproductive system

Sites / Locations

  • RSUPN Cipto MangunkusumoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Sham Comparator

Experimental

Experimental

Experimental

Arm Label

Amnion only

Amnion- self endometrium stem cells (EnSC)

Amnion- amnion epithelial stem cells (AESC)

Amnion- co culture self EnSC - AESC

Arm Description

Amnion bilayer as a scaffold to overlay the endometrium, with minor curettage prior to stick the scaffold.

Amnion bilayer as a scaffold, seeded with endometrium stem cells to regenerate the thin endometrium.

Amnion bilayer as a scaffold, seeded with amnion epithelial stem cells to regenerate the thin endometrium.

Amnion bilayer as a scaffold, seeded with co-culture of endometrium stem cells and amnion epithelial stem cells to regenerate the thin endometrium.

Outcomes

Primary Outcome Measures

Change in endometrium thickness
Observation by USG
Change in amenorrhea severity
Patients' report

Secondary Outcome Measures

Full Information

First Posted
December 2, 2020
Last Updated
December 15, 2020
Sponsor
Indonesia University
search

1. Study Identification

Unique Protocol Identification Number
NCT04676269
Brief Title
Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients
Official Title
Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 9, 2019 (Actual)
Primary Completion Date
July 15, 2021 (Anticipated)
Study Completion Date
December 15, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indonesia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Severe infections or trauma to the endometrial lining causes permanent scars that disrupt the menstrual cycle and lead to conceive failure. Transplantation of biological graft seeded with stem cells is purposed to regenerate and recover the capability of the endometrial lining back into its cycles. Initially, the techniques to isolate and culture the endometrial cells and amnion epithelial stem cells were developed, then the endometrial cells form patients with thin endometrium. Tissue were obtained from hysteroscopic biopsy, weight between 100 µl, while up to 20 µl from the thin endometrium. Tissue were digested using collagenase-1 and cultured using DMEM-F12 added wit epidermal growth factor. Endometrial cells will be characterized to SSUD2, ICAM and BRCP1. Amnion epithelial stem cells (hAESC) will be isolated using collagenase-1 and hyaluronidase. Characterization towards TRA-1-60, SSEA-4, Oct 3/4, and Nanog. In the future, the cells will be co-culture on amnion bilayer, and stained using IHC against α-cadherin, estrogen receptor α, progesterone receptor. Endometrial receptivity (HOXA10, LIF (early secretory) adhesion, VEGF, osteopontin (SPP1) to indicate the pinopodes will be identified using qPCR.The SPP1, target of MIR424 expressed during the receptive phase.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cell- and Tissue-Based Therapy
Keywords
Endometrial stem cells, Amnion epithelial stem cells, Amnion bilayer, Thin endometrium, Secondary amenorrhoe

7. Study Design

Primary Purpose
Other
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
None of the participants, gynecologists, statistician, nurses nor of the participant' partners are informed about the treatment groups.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Amnion only
Arm Type
Sham Comparator
Arm Description
Amnion bilayer as a scaffold to overlay the endometrium, with minor curettage prior to stick the scaffold.
Arm Title
Amnion- self endometrium stem cells (EnSC)
Arm Type
Experimental
Arm Description
Amnion bilayer as a scaffold, seeded with endometrium stem cells to regenerate the thin endometrium.
Arm Title
Amnion- amnion epithelial stem cells (AESC)
Arm Type
Experimental
Arm Description
Amnion bilayer as a scaffold, seeded with amnion epithelial stem cells to regenerate the thin endometrium.
Arm Title
Amnion- co culture self EnSC - AESC
Arm Type
Experimental
Arm Description
Amnion bilayer as a scaffold, seeded with co-culture of endometrium stem cells and amnion epithelial stem cells to regenerate the thin endometrium.
Intervention Type
Biological
Intervention Name(s)
Amnion only
Intervention Description
Patients endometrium will be transplanted with amnion only (without seeded cells)
Intervention Type
Biological
Intervention Name(s)
Amnion - endometrium cells
Intervention Description
Patients endometrium will be transplanted with amnion seeded with endometrium cells isolated from the patients themselves
Intervention Type
Biological
Intervention Name(s)
Amnion - amnion epithelial cells
Intervention Description
Patients endometrium will be transplanted with amnion seeded with amnion epithelial stem cells isolated from other patients' caesarean sectio amnion membrane (tested HLA-DR negative to prevent rejection)
Intervention Type
Biological
Intervention Name(s)
Amnion-EnSC-AESC
Intervention Description
Patients endometrium will be transplanted with amnion seeded with endometrium cells-amnion epithelial stem cells co-culture
Primary Outcome Measure Information:
Title
Change in endometrium thickness
Description
Observation by USG
Time Frame
7 and 14 days after amnion bilayer seeded with endometrial cells co-cultured with hAESC is transplanted into patient' womb
Title
Change in amenorrhea severity
Description
Patients' report
Time Frame
7 and 14 days after amnion bilayer seeded with endometrial cells co-cultured with hAESC is transplanted into patient' womb

10. Eligibility

Sex
Female
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with thin endometrium without scar Patients with acute thin endometrium post-therapy (medicamentosa) Patients who are willing to participate in the study Exclusion Criteria: Patients with thin endometrium due to TB Patients with cancer in the reproductive system
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Achmad Kemal Harzif, MD
Phone
+62 813-1586-6390
Email
kemal.achmad@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Normalina Sandora, PhD
Phone
+62 812-9896-3425
Email
normalinasandora@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Achmad Kemal Harzif, MD
Organizational Affiliation
Faculty of Medicine, Indonesia University
Official's Role
Principal Investigator
Facility Information:
Facility Name
RSUPN Cipto Mangunkusumo
City
Jakarta Pusat
State/Province
DKI Jakarta
ZIP/Postal Code
10430
Country
Indonesia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Achmad Kemal Harzif, MD
Phone
+6281315866390
Email
kemal.achmad@gmail.com
First Name & Middle Initial & Last Name & Degree
Normalina Sandora, PhD
Phone
+6281298963425
Email
normalina.sandora@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients

We'll reach out to this number within 24 hrs